Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1978 1
1980 1
1981 1
1983 1
1985 1
1986 2
1987 1
1988 1
1989 1
1990 2
1991 2
1992 1
1993 3
1994 2
1995 2
1997 3
1998 4
1999 4
2000 5
2001 2
2002 2
2003 8
2004 12
2005 20
2006 16
2007 11
2008 12
2009 14
2010 17
2011 10
2012 13
2013 14
2014 12
2015 7
2016 11
2017 12
2018 6
2019 8
2020 8
2021 7
2022 4
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

251 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for spasmolyt
Your search for pasmolit retrieved no results
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline-trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial.
Kaul I, Sawchak S, Correll CU, Kakar R, Breier A, Zhu H, Miller AC, Paul SM, Brannan SK. Kaul I, et al. Lancet. 2024 Jan 13;403(10422):160-170. doi: 10.1016/S0140-6736(23)02190-6. Epub 2023 Dec 14. Lancet. 2024. PMID: 38104575 Clinical Trial.
Xanomeline-trospium (KarXT) combines xanomeline with the peripherally restricted muscarinic receptor antagonist trospium chloride with the goal of ameliorating xanomeline-related adverse events associated with peripheral muscarinic receptors. ...
Xanomeline-trospium (KarXT) combines xanomeline with the peripherally restricted muscarinic receptor antagonist trospium chloride
Painful sweating.
Goldstein DS, Pechnik S, Moak J, Eldadah B. Goldstein DS, et al. Neurology. 2004 Oct 26;63(8):1471-5. doi: 10.1212/01.wnl.0000142037.06255.a8. Neurology. 2004. PMID: 15505167
The patient reported benefit from tricyclic antidepressants, guanethidine, and trospium chloride (an anti-cholinergic quaternary amine used in Europe for urinary urgency). ...RESULTS: Administration of edrophonium IV evoked pain and sweating, and ganglion blockade b …
The patient reported benefit from tricyclic antidepressants, guanethidine, and trospium chloride (an anti-cholinergic quaterna …
Overactive bladder - pharmacological treatment.
Sacomani CAR, Almeida FG, Silvinato A, Bernardo WM. Sacomani CAR, et al. Rev Assoc Med Bras (1992). 2019 May 2;65(4):487-492. doi: 10.1590/1806-9282.65.4.487. Rev Assoc Med Bras (1992). 2019. PMID: 31066800 Free article.
Editorial comment.
Blok BF. Blok BF. Urology. 2010 Apr;75(4):877; author reply 877-8. doi: 10.1016/j.urology.2009.09.072. Urology. 2010. PMID: 20371063 No abstract available.
Cognitive Effects of Anticholinergic Load in Women with Overactive Bladder.
Araklitis G, Robinson D, Cardozo L. Araklitis G, et al. Clin Interv Aging. 2020 Aug 25;15:1493-1503. doi: 10.2147/CIA.S252852. eCollection 2020. Clin Interv Aging. 2020. PMID: 32921995 Free PMC article. Review.
In view of this, care is needed when treating OAB in the elderly. Trospium chloride is a quaternary amine anticholinergic, which has a molecular structure, which theoretically means it is less likely to cross the blood brain barrier and exert central side effects. . …
In view of this, care is needed when treating OAB in the elderly. Trospium chloride is a quaternary amine anticholinergic, whi …
The patent review of the biological activity of tropane containing compounds.
Farghaly TA, Masaret GS, Abdulwahab HG. Farghaly TA, et al. Expert Opin Ther Pat. 2023 Dec;33(12):875-899. doi: 10.1080/13543776.2023.2299349. Epub 2024 Jan 15. Expert Opin Ther Pat. 2023. PMID: 38165255 Review.
Prominent examples of tropane-based drugs include hyoscine butylbromide, recognized for its antispasmodic properties, atropine, employed as a mydriatic, maraviroc, known for its antiviral effects. trospium chloride, utilized as a spasmolytic for overactive bladder, …
Prominent examples of tropane-based drugs include hyoscine butylbromide, recognized for its antispasmodic properties, atropine, employed as …
Clinical pharmacokinetics of trospium chloride.
Doroshyenko O, Jetter A, Odenthal KP, Fuhr U. Doroshyenko O, et al. Clin Pharmacokinet. 2005;44(7):701-20. doi: 10.2165/00003088-200544070-00003. Clin Pharmacokinet. 2005. PMID: 15966754 Review.
Trospium chloride, a quaternary amine with anticholinergic properties, is used for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and urinary frequency. The pharmacokinetics of trospium chloride have been invest
Trospium chloride, a quaternary amine with anticholinergic properties, is used for the treatment of overactive bladder with sy
Trospium chloride treatment of overactive bladder.
Biastre K, Burnakis T. Biastre K, et al. Ann Pharmacother. 2009 Feb;43(2):283-95. doi: 10.1345/aph.1L160. Epub 2009 Feb 3. Ann Pharmacother. 2009. PMID: 19193592 Review.
OBJECTIVE: To review the pharmacology, pharmacokinetics, safety, and clinical application of trospium chloride for the management of overactive bladder (OAB). DATA SOURCES: Clinical literature including both primary sources and review articles was accessed through M …
OBJECTIVE: To review the pharmacology, pharmacokinetics, safety, and clinical application of trospium chloride for the managem …
251 results